0001140361-15-014738.txt : 20150408
0001140361-15-014738.hdr.sgml : 20150408
20150408163220
ACCESSION NUMBER: 0001140361-15-014738
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150407
FILED AS OF DATE: 20150408
DATE AS OF CHANGE: 20150408
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalanche Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001501756
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 205258327
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1035 O?BRIEN DRIVE, SUITE A
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-272-6269
MAIL ADDRESS:
STREET 1: 1035 O?BRIEN DRIVE, SUITE A
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hull Hans
CENTRAL INDEX KEY: 0001614876
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36579
FILM NUMBER: 15759383
MAIL ADDRESS:
STREET 1: C/O AVALANCHE BIOTECHNOLOGIES, INC.
STREET 2: 1035 O'BRIEN DRIVE, SUITE A
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc1.xml
FORM 4
X0306
4
2015-04-07
0
0001501756
Avalanche Biotechnologies, Inc.
AAVL
0001614876
Hull Hans
C/O AVALANCHE BIOTECHNOLOGIES, INC.
1035 O'BRIEN DRIVE, SUITE A
MENLO PARK
CA
94025
0
1
0
0
SVP, Business Operations
Common Stock
2015-04-07
4
M
0
27500
0.19
A
30820
D
Common Stock
2015-04-07
4
S
0
26613
38.5874
D
4207
D
Common Stock
2015-04-07
4
S
0
887
39.0603
D
3320
D
Stock Option (Right to Buy)
0.19
2015-04-07
4
M
0
27500
0.00
D
2022-02-23
Common Stock
27500
27500
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
This transaction was executed in multiple trades in prices ranging from $38.02 to $39.00, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
This transaction was executed in multiple trades in prices ranging from $39.025 to $39.16, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The shares subject to the option vest and become exercisable in 48 successive, equal monthly installments on each monthly anniversary of February 1, 2012, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
/s/ Hans Hull
2015-04-08